Will Stone
[Copyright 2024 NPR]
-
Wellness and longevity influencers are pushing a compound called NAD+. There's scientific interest in its potential, but researchers say the marketing claims have gotten ahead of the science.
-
Researchers evaluated how well an AI model could diagnose and make decisions about patient care in the ER.
-
The Trump administration is easing restrictions on medical marijuana. The acting attorney general issued a memo saying he is moving the cannabis products out of the most restrictive category.
-
President Trump has signed an executive order aimed at accelerating research and approval of psychedelics for treating mental health conditions, like depression, PTSD and addiction.
-
A major concern for the Make America Healthy Again movement is the harmful effects of chemicals and toxins, but the coalition is growing increasingly frustrated by the Trump administration's actions.
-
In his first appearance this year, the health secretary is taking questions on his record on health, including his controversial moves on vaccines.
-
There is public concern about health risks from the chemicals, especially from the Make America Healthy Again movement. The agency's move doesn't in itself guarantee regulation.
-
Peptide therapies for wellness and longevity are popular, but safety concerns led the FDA to place more stringent requirements on them. Now Health Secretary Kennedy says the rules will likely loosen.
-
Health officials with the Trump administration have backed away from an effort to more heavily regulate indoor tanning — despite protests from medical groups that warn of the dangers of skin cancer.
-
Many people say they use cannabis for their mental health, but researchers find there is little to no evidence that cannabis can be beneficial for any psychiatric condition.